Stockholders’ Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
Oct. 07, 2020 |
Jan. 31, 2018 |
Jan. 31, 2023 |
Jan. 31, 2022 |
Jan. 31, 2023 |
Jan. 31, 2022 |
Jul. 31, 2022 |
Sep. 30, 2017 |
Jan. 31, 2011 |
|
| Stockholders’ Equity (Details) [Line Items] | |||||||||
| Common stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | ||||||
| Percentage of commission payable on equity offering | 3.00% | ||||||||
| Common stock available for grant, description | The amendment and restatement of the Amended and Restated 2011 Plan was for purposes of, among other things, (i) increasing the shares of common stock available for grant under the Amended and Restated 2011 Plan by an additional 4,000,000 shares of common stock bringing the total number of shares available for grant to 9,000,000 shares of common stock and (ii) extending the term of the Amended and Restated 2011 Plan until October 7, 2030. | ||||||||
| Common stock granted (in Shares) | 3,874,000 | 3,874,000 | |||||||
| Excess tax benefits | |||||||||
| Total future compensation cost | 2,344 | $ 2,344 | |||||||
| Weighted average remaining life of approximately | 2 years | ||||||||
| 2011 Plan [Member] | |||||||||
| Stockholders’ Equity (Details) [Line Items] | |||||||||
| Stock units (in Shares) | 3,000,000 | ||||||||
| Shares of common stock (in Shares) | 2,000,000 | ||||||||
| Common stock available for grants (in Shares) | 5,000,000 | ||||||||
| Common Stock [Member] | |||||||||
| Stockholders’ Equity (Details) [Line Items] | |||||||||
| Authorized common stock that may be issued and sold under sales agreement | $ 19,200,000 | ||||||||
| Phantom Share Units (PSUs) [Member] | |||||||||
| Stockholders’ Equity (Details) [Line Items] | |||||||||
| Remaining PSUs awarded expired | 3 years | ||||||||
| Performance share, description | During the fiscal years ended 2020 and 2019, the Company awarded additional PSUs to its executive officers. These awards provide for the grant of shares of our common stock at the end of a three-year period based on the achievement of revenue growth and adjusted EBITDA growth goals met at threshold, target or maximum levels over the respective period. The PSUs awarded to executive officers in fiscal 2019, net of forfeitures, were earned as of the three-year period ending July 31, 2022 as the growth goals at the maximum level were achieved. After TSR modification, a total of 25,200 PSUs were earned equally by two officers. As of January 31, 2023, 12,600 shares had been issued and the balance of the shares are expected to be issued in the third quarter of fiscal 2023. | ||||||||
| Former officer forfeited shares (in Shares) | 15,000 | ||||||||
| Shared based compensation expense | 7 | $ 96 | $ (48) | $ 162 | |||||
| Restricted Stock Units (RSUs) [Member] | |||||||||
| Stockholders’ Equity (Details) [Line Items] | |||||||||
| Shared based compensation expense | $ 202 | $ 73 | 388 | $ 73 | |||||
| Unrecognized compensation | $ 995,000 | ||||||||